What is the Interventional Radiology Products Market Size in 2026?
The global interventional radiology products market size accounted for USD 30.60 billion in 2025 and is predicted to increase from USD 32.93 billion in 2026 to approximately USD 63.66 billion by 2035, expanding at a CAGR of 7.60% from 2026 to 2035. The market is driven by the rising adoption of minimally invasive procedures, advancements in imaging technologies, and the increasing prevalence of chronic diseases.
Key Takeaways
- North America led the market with a major share of 38% in 2025.
- Asia Pacific is expected to grow at the fastest CAGR of 8.0% during the forecast period.
- By product type, the stents segment held the largest market share of 32% in 2025.
- By product type, the catheters segment is expected to expand with the highest CAGR of 6.2% during the forecast period.
- By procedure type, the angioplasty segment dominated the market with a share of 34% in 2025.
- By procedure type, the embolization segment is expected to rise with the fastest CAGR of 6.4% during the forecast period.
- By application, the cardiology segment led the market with a share of 30% in 2025.
- By application, the oncology segment is expected to grow at a significant rate in the coming years.
- By end-user, the hospitals segment led the market with a share of 56% in 2025.
- By end-user, the ambulatory surgical centers segment is expected to expand with the highest CAGR of 6.8% during the forecast period.
- By imaging modality, the fluoroscopy/angiography segment dominated the market with a share of 42% in 2025.
- By imaging modality, the CT-guided imaging segment is expected to grow with the fastest CAGR of 6.5% during the forecast period.
What are Interventional Radiology (IR) Products?
Interventional radiology (IR) products are specialized medical devices used in minimally invasive, image-guided procedures for the diagnosis and treatment of a wide range of diseases. These products include catheters, stents, guidewires, embolization devices, angioplasty balloons, and biopsy needles, all of which are guided using advanced imaging modalities such as fluoroscopy, computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI).
IR products enable highly precise treatment of conditions such as cardiovascular diseases, cancer, and vascular disorders, while significantly reducing surgical risks, hospital stays, and recovery time compared to traditional surgical approaches. They are widely utilized in hospitals and specialty clinics to support advanced diagnostic and therapeutic interventions. With the continuous expansion of global healthcare infrastructure and the rising volume of minimally invasive procedures, the interventional radiology products market is poised for substantial growth.
How is AI Influencing the Interventional Radiology Products Market?
Artificial intelligence (AI) is playing a transformative role in the interventional radiology market by enhancing imaging precision, enabling real-time procedural guidance, and improving clinical workflow efficiency. These advancements contribute to safer, faster, and more accurate minimally invasive treatments.
AI technologies facilitate the integration of pre-procedural 3D imaging data (from CT and MRI scans) with real-time 2D imaging, such as fluoroscopy, allowing clinicians to guide catheters and needles with enhanced accuracy. Additionally, AI-powered imaging systems can automatically identify anatomical structures, track needle placement, and detect critical features such as tumors and blood vessels, thereby improving procedural outcomes and reducing human error.
For example, in September 2025, GE Healthcare introduced the Voluson Performance series ultrasound systems, incorporating AI capabilities to support clinicians across a wide range of surgical and diagnostic procedures.
Interventional Radiology Products Market Trends
- Strategic Collaborations: Medical device manufacturers are increasingly partnering with pharmaceutical and technology companies to develop advanced interventional radiology solutions. For instance, in September 2025, Cook Medical collaborated with Siemens Healthineers to develop next-generation interventional MRI suites, enhancing precision and clinical capabilities.
- Product Innovation and Launches: Leading companies are actively launching innovative IR products to strengthen their market presence. In May 2025, Johnson & Johnson introduced a new ultrasound catheter designed to deliver high-resolution imaging, improved maneuverability, and seamless integration with advanced mapping systems for cardiac ablation procedures.
- Capacity Expansion Initiatives: Market players are investing in expanding manufacturing capabilities to meet the rising global demand for IR products. For example, in July 2025, Varex Imaging established a new production facility in Andhra Pradesh, India, to increase the manufacturing of interventional cardiology equipment and support regional demand.
- Healthcare Infrastructure Development: Governments across various countries are investing in new healthcare facilities to improve access to advanced medical treatments. In June 2025, the government of Tamil Nadu, India, announced an investment of approximately INR 197.81 crores to establish a multi-specialty government hospital in Vellore, which is expected to drive demand for interventional radiology products.
- Rising Burden of Chronic Diseases: The increasing prevalence of chronic conditions, particularly cardiovascular diseases and cancer, is significantly driving demand for interventional radiology procedures. For instance, according to the American Cancer Society, a substantial rise in cancer cases is anticipated, further increasing the need for advanced diagnostic and minimally invasive treatment solutions.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 30.60 Billion |
| Market Size in 2026 | USD 32.93 Billion |
| Market Size by 2035 | USD 63.66 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 7.60% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product Type, Procedure Type, Application, End-User, Imaging Modality, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Regional Insights
North America dominates the interventional radiology products market, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of leading medical device manufacturers. The United States plays a key role, supported by rising cases of chronic diseases such as cancer and cardiovascular conditions, along with high healthcare spending and continuous technological innovation.
Europe represents a significant market share, supported by well-established healthcare systems and increasing demand for minimally invasive treatments. Countries such as Germany, the UK, and France are at the forefront, benefiting from strong regulatory frameworks and growing investments in advanced imaging technologies. Additionally, the region’s aging population is contributing to higher demand for interventional radiology procedures.
Asia-Pacific is the fastest-growing region in the interventional radiology products market, fueled by rapid healthcare infrastructure development, rising medical tourism, and increasing investments in advanced medical technologies. Countries such as China, India, Japan, and South Korea are witnessing strong growth due to expanding patient populations and increasing awareness of minimally invasive treatments. The growing number of hospitals and diagnostic centers further supports market expansion.
Latin America is an emerging market with steady growth potential, driven by improving healthcare infrastructure and increasing adoption of advanced medical procedures. Brazil and Mexico are key contributors, with rising demand for cost-effective and minimally invasive treatment options. However, limited access to advanced technologies in certain areas may restrain rapid growth.
The Middle East & Africa region is gradually gaining traction, supported by growing investments in healthcare infrastructure and increasing focus on modern medical technologies. Gulf countries such as the UAE and Saudi Arabia are investing in advanced radiology equipment and hospital development. Meanwhile, Africa presents long-term growth opportunities, although challenges such as limited infrastructure and skilled professionals remain.
Interventional Radiology Products Market Supply Chain Analysis
Interventional Radiology Products Market Key Players
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Terumo Corporation
- Stryker Corporation
- Cook Medical
- Teleflex Incorporated
- Biosensors International Group
- Meril Life Sciences
- BIOTRONIK SE & Co. KG
- AngioDynamics, Inc.
- Cardinal Health
- B. Braun Melsungen AG
- Penumbra, Inc.
Recent Developments
- In March 2026, Esaote launched the new MyLab E85 GTS ultrasound system. This system is designed for interventional radiologists to enhance computed tomography (CT)-guided interventional procedures.
- In January 2026, Boston Scientific acquired Penumbra. This acquisition is aimed at developing a wide range of embolization devices for treating heart patients.
- In December 2025, Canon launched Aquilion ONE/INSIGHT Edition. Aquilion ONE is a 4D CT device designed for performing interventional procedures.
- In August 2025, Sonio launched a new series of ultrasound systems. This new series of ultrasound units is designed for the healthcare sector of the U.S.
Segments Covered in the Report
By Product Type
- Stents
- Catheters
- Guidewires
- Angioplasty Balloons
- Embolization Devices
- Others (IVC Filters, Biopsy Needles, Accessories)
By Procedure Type
- Angioplasty
- Angiography
- Embolization
- Thrombolysis
- Biopsy & Drainage
By Application
- Cardiology
- Oncology
- Gastroenterology
- Neurology
- Urology & Nephrology
- Orthopedics
By End-User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
By Imaging Modality
- Fluoroscopy/Angiography
- CT-Guided Imaging
- Ultrasound
- MRI
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
Get Sample Link: https://www.precedenceresearch.com/sample/8185
Also Read : https://www.businesswebwire.com/emc-testing-market/